InvestorsHub Logo
Followers 1
Posts 36
Boards Moderated 0
Alias Born 11/16/2018

Re: None

Friday, 11/16/2018 8:37:36 AM

Friday, November 16, 2018 8:37:36 AM

Post# of 18784
Novo Nordisk recently paid $181 million dollars upfront for the commercial rights to Macrilen for only the USA and Canada not including royalties that Novo will pay to both AEZS and SBBP for sales of Macrilen in the USA and Canada. AEZS still controls FULL rights to Macrilen worldwide outside of the USA and Canada. Can you imagine what Novo Nordisk or other big Pharma will pay AEZS for the rights to Macrilen in Europe, Asia, and other markets worldwide outside of the USA and Canada. Market cap is only about 40 Million dollars right now. Imagine how much AEZS share price and market cap will grow soon. HUGE news today. Great investment.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AEZS News